LD-2 disclosure · 2nd Quarter - Report
GLENMARK PHARMACEUTICALS, INC., USA
Client
- Description
- Leading,integrated, research-driven, global pharmaceutical manufacturing company.
- Location
- New Jersey · United States of America
Registrant
- Description
- Federal lobbying and consulting services
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
General education about the generic pharmaceutical industry.
Lobbyistsms MARY R "RANDI" REID · DAVID PAUL PELUSO · MJ KENNY · ADAM HECHAVARRIA · LISA KOUNTOUPES
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Medicare/Medicaid
Issues related to Medicaid CPI Penalty. Issues related to the implementation of H.R. 748, Cornonavirus Aid, Relief, and Economic Security Act (CARES Act), including Medicaid provisions. Issues related to Medicaid provisions in H.R. 6800, the HEROES Act.
LobbyistsJULIE HERSHEY CARR · DAVID PAUL PELUSO · MJ KENNY · ADAM HECHAVARRIA · LISA KOUNTOUPES
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Pharmacy
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals. Issues related to the implementation of H.R. 748, Coronavirus Aid, Relief, and Economic Security Act (CARES Act), including drug supply chain dynamics. H.R. 6800, the HEROES Act. Issues related to the federal response to the COVID-19 pandemic.
Lobbyistsms MARY R "RANDI" REID · DAVID PAUL PELUSO · MJ KENNY · ADAM HECHAVARRIA · LISA KOUNTOUPES